Clinical Trial Update: Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial comparing cyclophosphamide plus abatacept with standard of care after allogeneic stem cell transplantation for graft-versus-host disease and hemat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Hematologic Neoplasms

Drugs mentioned

• Abatacept (abatacept)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Dimitrios Tzachanis, MD PhD | Conditions: GVHD, Hematologic Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2024-10-02